Senior insider sale
Chief Medical Officer at REVOLUTION MEDICINES, INC. — senior position signals high conviction
$185.7K
4.30K shares
What this filing means
WEI LIN plans to sell 4.30K shares of REVOLUTION MEDICINES, INC. valued at approximately $185.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/15/2025ACC: 0001872772-25-000006
Officer· Chief Medical Officer
Since Mar 2026
4.30K
Shares to sell
$185.7K
Approx. market value
2.13K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months3
Restricted stock unit grant
Services rendered
3/1/2025
466.00Restricted stock unit grant
Services rendered
3/1/2024
412.00Restricted stock unit grant
Services rendered
5/1/2023
1.25KTotal acquired2.13K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/1/2025 | Restricted stock unit grant Services rendered | 466.00 | — |
3/1/2024 | Restricted stock unit grant Services rendered | 412.00 | — |
5/1/2023 | Restricted stock unit grant Services rendered | 1.25K | — |
| Total | 2.13K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
2.17K
Market value
$86.6K
6/16/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
2.13K
Market value
$99.2K
9/15/2025
Total
Units
4.30K
Value
$185.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/16/2025 | 2.17K | $86.6K | — | Completed |
| Planned — Approximate Date | ||||
9/15/2025 | 2.13K | $99.2K | NASDAQ | Planned |
| Total | 4.30K | $185.7K | ||